2025-10-27 – Press Releases – www.prnewswire.com
SAP-001 is Shanton’s lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., Oct. 27, 2025 /PRNewswire/ — Shanton Pharma, a clinical-stage biotech developing a novel treatment for gout, today announced the successful…
